Novel |
BOD1L1 |
biorientation of chromosomes in cell division 1 like 1 |
|
|
|
Novel |
CLNK |
cytokine dependent hematopoietic cell linker |
|
|
|
Novel |
HTRA3 |
HtrA serine peptidase 3 |
|
|
|
Novel |
MKX |
mohawk homeobox |
|
|
|
Novel |
MRFAP1L1 |
Morf4 family associated protein 1 like 1 |
|
|
|
Novel |
NKX2-1 |
NK2 homeobox 1 |
|
|
- Choreoathetosis, hypothyroidism, and neonatal respiratory distress
|
Novel |
TADA2B |
transcriptional adaptor 2B |
- HATs acetylate histones
- Ub-specific processing proteases
|
|
|
Novel |
TRMT44 |
tRNA methyltransferase 44 homolog |
- tRNA modification in the nucleus and cytosol
|
|
|
|
BLK |
BLK proto-oncogene, Src family tyrosine kinase |
- RUNX1 regulates transcription of genes involved in BCR signaling
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Fostamatinib
- Zanubrutinib
|
- Maturity onset diabetes of the young (MODY)
|
|
C18orf25 |
chromosome 18 open reading frame 25 |
|
|
|
|
CBX8 |
chromobox 8 |
- Oxidative Stress Induced Senescence
- SUMOylation of DNA damage response and repair proteins
- SUMOylation of transcription cofactors
- SUMOylation of chromatin organization proteins
- SUMOylation of RNA binding proteins
- SUMOylation of DNA methylation proteins
- RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
|
|
|
|
CHRM3 |
cholinergic receptor muscarinic 3 |
- Muscarinic acetylcholine receptors
- Acetylcholine regulates insulin secretion
- G alpha (q) signalling events
|
- Cevimeline
- Tramadol
- Succinylcholine
- Trospium
- Ziprasidone
- Disopyramide
- Amitriptyline
- Ipratropium
- Olanzapine
- Metixene
- Terfenadine
- Clozapine
- Doxylamine
- Trihexyphenidyl
- Oxyphencyclimine
- Procyclidine
- Loxapine
- Carbamoylcholine
- Hyoscyamine
- Cyproheptadine
- Meperidine
- Imipramine
- Methscopolamine bromide
- Chlorpromazine
- Darifenacin
- Haloperidol
- Tridihexethyl
- Anisotropine methylbromide
- Nortriptyline
- Amoxapine
- Cinnarizine
- Atropine
- Thiopental
- Nicardipine
- Paroxetine
- Homatropine methylbromide
- Trimipramine
- Scopolamine
- Benzquinamide
- Propiomazine
- Tropicamide
- Brompheniramine
- Maprotiline
- Methantheline
- Glycopyrronium
- Bethanechol
- Tolterodine
- Oxybutynin
- Promethazine
- Pilocarpine
- Doxepin
- Desipramine
- Ketamine
- Quetiapine
- Mivacurium
- Diphenidol
- Aripiprazole
- Chlorprothixene
- Pancuronium
- Pipecuronium
- Methotrimeprazine
- Tiotropium
- Solifenacin
- Isopropamide
- Acetylcholine
- Arecoline
- Mepenzolate
- ALKS 27
- Pizotifen
- Fesoterodine
- Methacholine
- Hexocyclium
- Aclidinium
- Umeclidinium
- Trimebutine
- Dosulepin
- Etoperidone
- Imidafenacin
- Butylscopolamine
- Homatropine
- Thonzylamine
- Revefenacin
- Propiverine
- Rociverine
- Diphemanil
- Aripiprazole lauroxil
|
|
|
DDX6 |
DEAD-box helicase 6 |
- mRNA decay by 5' to 3' exoribonuclease
|
|
|
|
ENKD1 |
enkurin domain containing 1 |
|
|
|
|
GABBR1 |
gamma-aminobutyric acid type B receptor subunit 1 |
- Activation of G protein gated Potassium channels
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- GABA B receptor activation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Baclofen
- Progabide
- Taurine
- gamma-Aminobutyric acid
- SGS-742
- Tezampanel
- Arbaclofen
- Arbaclofen Placarbil
|
|
|
IL16 |
interleukin 16 |
- Other interleukin signaling
|
|
|
|
JAK1 |
Janus kinase 1 |
- Interleukin-6 signaling
- Interleukin-6 signaling
- MAPK3 (ERK1) activation
- MAPK1 (ERK2) activation
- ISG15 antiviral mechanism
- Interleukin-7 signaling
- Interleukin-7 signaling
- Other interleukin signaling
- RAF/MAP kinase cascade
- Interleukin-10 signaling
- Interleukin-4 and Interleukin-13 signaling
- IL-6-type cytokine receptor ligand interactions
- Interferon gamma signaling
- Regulation of IFNG signaling
- Regulation of IFNG signaling
- Interleukin-20 family signaling
- Interleukin-15 signaling
- Interleukin-15 signaling
- Interleukin-35 Signalling
- Interleukin-9 signaling
- Interleukin-2 signaling
- Interleukin-12 signaling
- Interleukin-12 signaling
- Interleukin-27 signaling
- Interleukin-27 signaling
- Interleukin-21 signaling
- Interferon alpha/beta signaling
- Interleukin receptor SHC signaling
- Regulation of IFNA signaling
- Regulation of IFNA signaling
- Potential therapeutics for SARS
|
- Myricetin
- 2-tert-butyl-9-fluoro-1,6-dihydrobenzo[h]imidazo[4,5-f]isoquinolin-7-one
- Ruxolitinib
- Tofacitinib
- Baricitinib
- Fostamatinib
- Fedratinib
- Filgotinib
- Upadacitinib
- Pralsetinib
|
|
|
MCRS1 |
microspherule protein 1 |
- HATs acetylate histones
- UCH proteinases
- DNA Damage Recognition in GG-NER
|
|
|
|
MRPL11 |
mitochondrial ribosomal protein L11 |
- Mitochondrial translation initiation
- Mitochondrial translation elongation
- Mitochondrial translation elongation
- Mitochondrial translation termination
|
|
|
|
PSMB1 |
proteasome 20S subunit beta 1 |
- Activation of NF-kappaB in B cells
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- ER-Phagosome pathway
- Cross-presentation of soluble exogenous antigens (endosomes)
- Autodegradation of Cdh1 by Cdh1:APC/C
- SCF-beta-TrCP mediated degradation of Emi1
- APC/C:Cdc20 mediated degradation of Securin
- APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
- Cdc20:Phospho-APC/C mediated degradation of Cyclin A
- Vpu mediated degradation of CD4
- Vif-mediated degradation of APOBEC3G
- SCF(Skp2)-mediated degradation of p27/p21
- Degradation of beta-catenin by the destruction complex
- Downstream TCR signaling
- Regulation of activated PAK-2p34 by proteasome mediated degradation
- Separation of Sister Chromatids
- FCERI mediated NF-kB activation
- Autodegradation of the E3 ubiquitin ligase COP1
- Regulation of ornithine decarboxylase (ODC)
- ABC-family proteins mediated transport
- AUF1 (hnRNP D0) binds and destabilizes mRNA
- Asymmetric localization of PCP proteins
- Degradation of AXIN
- Degradation of DVL
- Hedgehog ligand biogenesis
- Hh mutants are degraded by ERAD
- Dectin-1 mediated noncanonical NF-kB signaling
- CLEC7A (Dectin-1) signaling
- Degradation of GLI1 by the proteasome
- Degradation of GLI2 by the proteasome
- GLI3 is processed to GLI3R by the proteasome
- Hedgehog 'on' state
- Regulation of RAS by GAPs
- TNFR2 non-canonical NF-kB pathway
- NIK-->noncanonical NF-kB signaling
- Defective CFTR causes cystic fibrosis
- MAPK6/MAPK4 signaling
- UCH proteinases
- Ub-specific processing proteases
- Neutrophil degranulation
- CDT1 association with the CDC6:ORC:origin complex
- Orc1 removal from chromatin
- CDK-mediated phosphorylation and removal of Cdc6
- G2/M Checkpoints
- Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
- Ubiquitin-dependent degradation of Cyclin D
- The role of GTSE1 in G2/M progression after G2 checkpoint
- FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
- Regulation of RUNX2 expression and activity
- Regulation of RUNX2 expression and activity
- Regulation of RUNX3 expression and activity
- Regulation of PTEN stability and activity
- Neddylation
- Regulation of expression of SLITs and ROBOs
- Interleukin-1 signaling
- Negative regulation of NOTCH4 signaling
- Antigen processing: Ubiquitination & Proteasome degradation
|
- Bortezomib
- (3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE
- Carfilzomib
|
|